llámanos
902 58 55 40 | 628 308 308

Infórmate sin compromiso

Nombre:  
Apellido 1:  
Apellido 2:  
Telefono:  
Email:  
Provincia:
 
Comentarios:
 
aviso legal
 
Está en:  Inicio
cancer del próstata

Bibliografía

Está demostrado que el organismo a través de la orina expulsa la clave para la curación de un gran porcentaje de enfermedades, entre ellas el cancer y el cancer de próstata.

Muchos investigadores entre ellos Dr. Salvador Capistrán que llevan años investigando los tumores cancerígenos han desarrollado vacunas personalizadas elaboradas con los propios antígenos del paciente están consiguiendo la cura a muchas enfermedades derivadas del cancer y sus adversidades.

Con más de 8000 pacientes tratados con esta terapia natural sin efectos secundarios ni reacciones adversas, es seguramente la vacuna del futuro que acabara con la peor enfermedad del siglo XXI

Podrás encontrar más información de estas vacunas en el siguiente artículo de la revista Discovery Salud:

Zou W.

Regulatory T cells, tumour immunity and immunotherapy.
Nature Reviews Immunology 2006; 6(4):295–307. [PubMed Abstract)

Garnett CT, Greiner JW, Tsang KY, et al.

TRICOM vector based cancer vaccines.
Current Pharmaceutical Design 2006; 12(3):351–361. [PubMed Abstract]

Ng LG, Mrass P, Kinjyo I, Reiner SL, Weninger W.

Two-photon imaging of effector T-cell behavior: lessons from a tumor model.
Immunological Reviews 2008; 221:147–162. [PubMed Abstract]

Schlom J, Arlen PM, Gulley JL.

Cancer vaccines: moving beyond current paradigms.
Clinical Cancer Research 2007; 13(13):3776–3782. [PubMed Abstract]

Emens LA.

Chemotherapy and tumor immunity: an unexpected collaboration.
Frontiers in Bioscience 2008; 13:249–257. [PubMed Abstract]

Herr HW, Morales A.

History of Bacillus Calmette-Guérin and bladder cancer: an immunotherapy success story.
The Journal of Urology 2008; 179(1):53–56. [PubMed Abstract]

Chiarella P, Massi E, De Robertis M, Signori E, Fazio VM.

Adjuvants in vaccines and for immunisation: current trends.
Expert Opinion on Biological Therapy 2007; 7(10):1551–1562. [PubMed Abstract]

Curigliano G, Spitaleri G, Dettori M, et al.

Vaccine immunotherapy in breast cancer treatment: promising, but still early.
Expert Review of Anticancer Therapy 2007; 7(9):1225–1241. [PubMed Abstract]

Finn OJ.

Cancer immunology.
The New England Journal of Medicine 2008; 358(25):2704–2715. [PubMed Abstract]

Parmiani G, De Filippo A, Novellino L, Castelli C.

Unique human tumor antigens: immunobiology and use in clinical trials.
The Journal of Immunology 2007; 178(4):1975–1979. [PubMed Abstract]

Parmiani G, De Filippo A, Novellino L, Castelli C.

Unique human tumor antigens: immunobiology and use in clinical trials.
The Journal of Immunology 2007; 178(4):1975–1979. [PubMed Abstract]

Kantoff PW, Higano CS, Shore ND, et al.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
New England Journal of Medicine 2010; 363(5):411–422. [PubMed Abstract]

Parmiani G, Russo V, Marrari A, et al.

Universal and stemness-related tumor antigens: potential use in cancer immunotherapy.
Clinical Cancer Research 2007; 13(19):5675–5679. [PubMed Abstract]

Renkvist N, Castelli C, Robbins PF, Parmiani G.

A listing of human tumor antigens recognized by T cells.
Cancer Immunology and Immunotherapy 2001; 50(1):3–15. [PubMed Abstract]

Rosenberg SA, Yang JC, Restifo NP.

Cancer immunotherapy: moving beyond current vaccines.
Nature Medicine 2004; 10(9):909–915. [PubMed Abstract]

Rivoltini L, Canese P, Huber V, et al.

Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control? Expert Opinion on Biological Therapy 2005;
5(4):463–476. [PubMed Abstract]

International Agency for Research on Cancer (2011).

Agents Classified by the IARC Monographs
Volumes 1–100. Retrieved November 15, 2011.

Mueller NE.

ancers caused by infections: unequal burdens.
C Cancer Epidemiology, Biomarkers & Prevention 2003; 12(3):237s. [PubMed Abstract]

U.S. Centers for Disease Control and Prevention.

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: immunization of infants, children, and adolescents.
Morbidity and Mortality Weekly Report 2005; 54(No. RR–16):1–31. [PubMed Abstract]

Lowy DR, Schiller JT.

Prophylactic human papillomavirus vaccines.
Journal of Clinical Investigation 2006; 116(5):1167–1173. [PubMed Abstract]

Parkin DM.

The global health burden of infection-associated cancers in the year 2002.
International Journal of Cancer 2006; 118(12):3030–3044. [PubMed Abstract]

Doorbar J.

Molecular biology of human papillomavirus infection and cervical cancer.
Clinical Science 2006; 110(5):525–541. [PubMed Abstract]

Frazer IH, Lowy DR, Schiller JT.

Prevention of cancer through immunization: prospects and challenges for the 21st century.
European Journal of Immunology 2007; 37(Suppl 1):S148–S155. [PubMed Abstract]

Lollini PL, Cavallo F, Nanni P, Forni G.

Vaccines for tumour prevention.
Nature Reviews Cancer 2006; 6(3):204–216. [PubMed Abstract]

Pazdur MP, Jones JL.

Vaccines: an innovative approach to treating cancer.
Journal of Infusion Nursing 2007; 30(3):173–178. [PubMed Abstract]

Sioud M.

An overview of the immune system and technical advances in tumor antigen discovery and validation.
Methods in Molecular Biology 2007; 360:277–318. [PubMed Abstract]

Emens LA.

Cancer vaccines: on the threshold of success.
Expert Opinion on Emerging Drugs 2008; 13(2):295–308. [PubMed Abstract]

Waldmann TA.

Effective cancer therapy through immunomodulation.
Annual Review of Medicine 2006; 57:65–81. [PubMed Abstract]

Murphy KM, Travers P

Walport M, editors.
Janeway's Immunobiology. 7th ed. New York: Garland Science, 2007

Pardoll DM. Cancer immunology. In:

Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, editors.
Abeloff's Clinical Oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008.

tumor en la prostata sintomas biopsia próstata cancer tratamiento cancer del próstata
2012| Desarrollo: dinamiq

Todos los tumores de cancer se pueden tratar de forma natural eliminando del tratamiento todas quimioterapias o procedimientos antinaturales perjudiciales para el cuerpo humano. Vacunas inmunes ayudan a superar enfermedades del cancer de forma natural, pide información específica para cada paciente

cancer del prostata

Compartir en facebook Compartir en Tuenti Compartir en twitter